Measurement bone collagen degradation hyperthyroidism thyroxine replacement therapy pyridinium cross-links specific urinary markers Urinary excretion bone collagen pyridinium cross-links pyridinoline PYD deoxypyridinoline DPD patients untreated thyrotoxicosis pre- postmenopausal women micrograms autoimmune hypothyroidism PYD DPD excretion nanomoles creatinine thyrotoxic patients controls median premenopausal women urinary pyridinium cross-link excretion serum osteocalcin levels similar control groups suppression serum TSH concentrations mU/L postmenopausal women SE urinary PYD excretion nanomoles creatinine relative controls DPD excretion serum osteocalcin levels women subnormal serum TSH difference PYD excretion marked mean DPD excretion Conclusion bone collagen breakdown thyrotoxicosis postmenopausal women sufficient serum TSH premenopausal women risk 